These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7863014)
1. On the significance of cholecystokinin receptors in panic disorder. van Megen HJ; den Boer JA; Westenberg HG Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1235-46. PubMed ID: 7863014 [TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin and panic disorder: past and future clinical research strategies. Bradwejn J; Koszycki D Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976 [TBL] [Abstract][Full Text] [Related]
3. [Is cholecystokinin a biological support in panic attacks?]. Bourin M; Bradwejn J; Koszycki D Encephale; 1991; 17(5):475-9. PubMed ID: 1686250 [TBL] [Abstract][Full Text] [Related]
4. The cholecystokinin hypothesis of anxiety and panic disorder. Bradwejn J; Koszycki D Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169 [No Abstract] [Full Text] [Related]
5. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Abelson JL; Nesse RM Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449 [TBL] [Abstract][Full Text] [Related]
6. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Bertoglio LJ; Zangrossi H Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394 [TBL] [Abstract][Full Text] [Related]
7. Vasodilatory effects of cholecystokinin: new role for an old peptide? Ruiz-Gayo M; González MC; Fernández-Alfonso S Regul Pept; 2006 Dec; 137(3):179-84. PubMed ID: 16889840 [TBL] [Abstract][Full Text] [Related]
8. CCK in anxiety and cognitive processes. Daugé V; Léna I Neurosci Biobehav Rev; 1998 Oct; 22(6):815-25. PubMed ID: 9809313 [TBL] [Abstract][Full Text] [Related]